Home page | Atrovent® HFA (ipratropium bromide HFA) Inhalation Aerosol
Learn how Atrovent® HFA (ipratropium bromide HFA) Inhalation Aerosol offers demonstrated efficacy and safety in COPD treatment. ATROVENT HFA is an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstruct
ATROVENT HFA, COPD, significant lung function improvement, low incidence of anticholinergic side effects, Atrovent efficacy, Atrovent safety, chronic bronchitis, emphysema, bronchospasm, chronic obstructive pulmonary disease
Is this your site? Certify your site and update informations
